Why the study?
What are the hemodynamic effects of isoproterenol and metaraminol in patients with severe cardiogenic shock?
Population
14 subjects with severe cardiogenic shock
Comparison
Isoproterenol and Metaraminol vs Baseline (before treatment)
Design
Case_series
Authors
Loading...
May inform agent selection by profile in shock; hypothesis-generating for outcome trials.
What are the hemodynamic effects of isoproterenol and metaraminol in patients with severe cardiogenic shock?
Isoproterenol and metaraminol demonstrate distinct hemodynamic profiles in severe cardiogenic shock, highlighting the need for tailored pharmacological support based on individual hemodynamic deficits.
Smith et al. (1967) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: